Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study

Erratum to: Diabetes Ther DOI 10.1007/s13300-017-0247-6

In the original publication, the data have been incorrectly updated within the results, discussion and Table 2. The correct data are given here.

The result in Table 2, presenting Hypoglycemic events at Week 12 currently reads: 2 (1.7).

This result should read: 2 (3.2).

The result in Table 2 presenting Hypoglycemic events at Week 36 reads: 3 (2.5).

This result should read: 3 (4.8).

The result in Table 2 presenting the Hypoglycemic events p value currently reads: 1.000.

This p value should read: 0.500.

The statement within the results section reads:

‘There was no significant difference in the incidence of hypoglycemia before and after treatment (1.7% vs. 2.5% χ ² = 0.21; p = 1.000) (Table 2).’

This statement should read:

‘There was no significant difference in the incidence of hypoglycemia before and after treatment (3.2% vs. 4.8% χ ² = 0.50; p = 0.500) (Table 2).’

Table 2 Changes in clinical parameters after 24 weeks’ basal-plus treatment

The statement the discussion section reads: ‘In particular, the 40% of subjects in the present study who.’

This statement should read: ‘In particular, the 36.7% of subjects in the present study who.’